Place more than four decades of experience on your team. We use a combination of underwriter contacts, global sources and contacts at large institutional funds to provide the TRUEST picture of how an IPO is shaping up prior to its debut. We are on your team. Additionally, we provide comprehensive research to outline short and long term risks of the new companies….. A full-service firm!
The IPO market inched its way into March with just one IPO that came with relatively little fanfare.
BioXcel Therapeutics (BTAI) slightly upsized its offering and priced at the low-end of the $11-$13 range. BTAI opened at $11.02, broke its offering price briefly before leveling out for the week. At its top tick, BioXcel touched $11.94 or 8.5% above the offering price but the majority of the trading volume was near the offering price. BioXcel Therapeutics closed the week at the offering price, $11.00.
Looking ahead to this week, there are three deals…which you can read a preview about by clicking on the images.
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish